Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Lancet HIV ; 11(1): e60-e62, 2024 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-37865118

RESUMO

A diagnosis of HIV poses secondary medical risks to patients, ranging from infections to neoplastic conditions. Regarding skin cancer, these risks extend beyond the well known association with Kaposi sarcoma and include Merkel cell carcinoma, squamous cell carcinoma, and high-risk melanomas. Despite evidence of these risks, knowledge and awareness remain low, among care providers for people living with HIV, individual patients, and even some specialists in dermatology. Crucially, medical organisations do not adequately address this concern, as there is an absence of treatment guidelines for the screening and management of skin cancer for people living with HIV. To continue providing high-quality care for this population, the increased risk of multiple high-risk skin cancers needs to be appropriately recognised by both providers and patients. Accordingly, we call for renewed emphasis on patient education and implementation of improved organisational guidelines for skin cancer screening protocols.


Assuntos
Infecções por HIV , Sarcoma de Kaposi , Neoplasias Cutâneas , Humanos , Infecções por HIV/complicações , Infecções por HIV/epidemiologia , Neoplasias Cutâneas/diagnóstico , Neoplasias Cutâneas/epidemiologia , Neoplasias Cutâneas/complicações , Sarcoma de Kaposi/epidemiologia , Risco
2.
Dermatol Surg ; 50(2): 125-130, 2024 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-37792642

RESUMO

BACKGROUND AND OBJECTIVE: Primary cutaneous melanoma incidence is increasing in elderly individuals. This population-based cohort examines incidence and mortality rates among adults aged 61 years and older with cutaneous melanoma. MATERIALS AND METHODS: Using the Rochester Epidemiology Project, patients aged 61 years of age or older with a first lifetime diagnosis of cutaneous melanoma between January 1, 1970 and December 31, 2020 were identified. RESULTS: The age- and sex-adjusted incidence rate increased from 16.4 (95% CI, 8.2-24.6) per 100,000 person-years in 1970 to 1979 to 201.5 (95% CI, 185.1-217.8) per 100,000 person-years in 2011 to 2020 (12.3-fold increase). There was a 16.0x increase in males and an 8.5× increase in females. Melanoma incidence has stabilized in males (1.2-fold increase, p = .11) and continues to significantly increase in females (2.7-fold increase, p < .001). Older age at diagnosis was significantly associated with an increased risk of death (HR 1.23 per 5-year increase in age at diagnosis, 95% CI, 1.02-1.47). CONCLUSION: Melanoma incidence continues to increase since 1970. The incidence has risen in elderly females, but has stabilized in males. Mortality has decreased throughout this period.


Assuntos
Melanoma , Neoplasias Cutâneas , Adulto , Idoso , Masculino , Feminino , Humanos , Pessoa de Meia-Idade , Melanoma/epidemiologia , Neoplasias Cutâneas/epidemiologia , Incidência , Minnesota/epidemiologia , Estudos Epidemiológicos
3.
Pediatr Dermatol ; 41(1): 46-50, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38014569

RESUMO

BACKGROUND: Bier anemic spots, cyanosis with urticaria-like eruption (BASCULE) syndrome is a recently described entity with episodic urticarial lesions and white anemic halos on a background of erythrocyanosis, commonly affecting the lower extremities. Possible association with autonomic dysfunction remains poorly understood. Existing publications are limited, but the condition is suggested as highly underrecognized. OBJECTIVE: To further characterize clinical and epidemiologic data for BASCULE syndrome. METHODS: We performed an IRB-approved retrospective chart review on patients with BASCULE syndrome evaluated at Mayo Clinic from April 2021 to November 2022. RESULTS: A total of 17 patients were identified (13 female, 4 male). Median age of onset was 12 years (range 9-17). Lower extremities were involved in all patients (17). Most patients were symptomatic with pruritus (8) or burning pain (8); three were asymptomatic. Triggers were standing (11), hot showers or hot environments (7), or no clear trigger (4). Autonomic dysfunction was present in 10 patients. Treatment responses were observed from propranolol (3) and high-dose cetirizine (1). CONCLUSION: Novel epidemiologic data from 17 pediatric and young adult patients with BASCULE syndrome further supports an association with autonomic dysfunction and suggests a higher prevalence than previously acknowledged.


Assuntos
Doenças do Sistema Nervoso Autônomo , Exantema , Urticária , Adulto Jovem , Humanos , Masculino , Feminino , Criança , Adolescente , Estudos Retrospectivos , Urticária/diagnóstico , Urticária/tratamento farmacológico , Urticária/epidemiologia , Síndrome , Cianose
6.
Mayo Clin Proc ; 98(5): 713-722, 2023 05.
Artigo em Inglês | MEDLINE | ID: mdl-37137643

RESUMO

OBJECTIVE: To identify changes in the incidence and mortality of cutaneous melanoma in the fastest-growing segment of the US population, middle-aged adults. PATIENTS AND METHODS: Using the Rochester Epidemiology Project, patients aged 40 to 60 years with a first lifetime diagnosis of cutaneous melanoma between January 1, 1970, and December 31, 2020, while a resident of Olmsted County, Minnesota, were identified. RESULTS: A total of 858 patients with a primary cutaneous first-time melanoma were identified. The overall age- and sex-adjusted incidence rate increased from 8.6 (95% CI, 3.9 to 13.3) per 100,000 person-years in 1970-1979 to 99.1 (95% CI, 89.5 to 108.7) per 100,000 person-years in 2011-2020 (11.6-fold increase). There was a 52.1-fold increase in women and a 6.3-fold increase in men between these 2 periods. In recent years (2005-2009 vs 2015-2020), the incidence has stabilized in men (1.01-fold increase; P=.96) and continues to significantly increase in women (1.5-fold increase; P=.002). Among 659 patients with invasive melanoma, 43 deaths were due to melanoma, and male sex was significantly associated with an increased risk of death (hazard ratio, 2.95; 95% CI, 1.45 to 6.00). A more recent diagnosis of melanoma was significantly associated with a decreased risk of death due to melanoma (hazard ratio, 0.66 per 5-year increase in calendar year of diagnosis; 95% CI, 0.59 to 0.75). CONCLUSION: Melanoma incidence has significantly increased since 1970. During the past 15 years, the incidence has continued to rise in middle-aged women (approximately 50% rise in incidence) but has stabilized in men. Mortality decreased in a linear fashion throughout this time.


Assuntos
Melanoma , Neoplasias Cutâneas , Pessoa de Meia-Idade , Adulto , Humanos , Masculino , Feminino , Melanoma/epidemiologia , Neoplasias Cutâneas/epidemiologia , Minnesota/epidemiologia , Incidência , Estudos Epidemiológicos , Síndrome
8.
J Clin Sleep Med ; 19(6): 1157-1159, 2023 06 01.
Artigo em Inglês | MEDLINE | ID: mdl-36789880

RESUMO

With increasing use of positive airway pressure devices for disordered breathing during sleep, appreciation for potential associated side effects is essential. Chondrodermatitis nodularis nasi is a rare variant of chondrodermatitis nodularis chronic helicis that presents as a nonhealing erosion or ulcer on the nose and can occur in association with chronic use of positive airway pressure devices. We present a case of symptomatic chondrodermatitis nodularis nasi associated with continuous positive airway pressure use, fully responsive to treatment, and propose that this condition is highly underrecognized. Dermatology referral can assist in diagnosis, management, and exclusion of cutaneous malignancy. CITATION: Reinhart JP, Isaq NA, Peters MS, Vidal NY. Continuous positive airway pressure device-associated nonhealing ulcer on the nasal dorsum: chondrodermatitis nodularis nasi. J Clin Sleep Med. 2023;19(6):1157-1159.


Assuntos
Dermatite , Otopatias , Humanos , Otopatias/diagnóstico , Otopatias/patologia , Otopatias/terapia , Úlcera , Pressão Positiva Contínua nas Vias Aéreas/efeitos adversos , Sono , Dermatite/diagnóstico , Dermatite/patologia , Dermatite/terapia
9.
Pediatr Dermatol ; 40(3): 519-522, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-36385392

RESUMO

Tumor necrosis factor-alpha inhibitor therapy for inflammatory bowel disease may be associated with paradoxical cutaneous adverse events, most commonly psoriasiform eruptions. We present the case of a pediatric female patient with Crohn's disease who developed multiple concurrent cutaneous eruptions while on infliximab treatment, including morphea, psoriasiform dermatitis, and genital lichen sclerosus. Although refractory to skin-directed treatments, all three conditions resolved upon discontinuation of infliximab, supporting their development as a paradoxical reaction to infliximab therapy.


Assuntos
Doença de Crohn , Eczema , Exantema , Esclerodermia Localizada , Dermatopatias , Humanos , Feminino , Criança , Doença de Crohn/tratamento farmacológico , Doença de Crohn/complicações , Infliximab/efeitos adversos , Esclerodermia Localizada/complicações , Fator de Necrose Tumoral alfa , Dermatopatias/patologia , Eczema/complicações
10.
Dermatol Clin ; 38(4): 467-476, 2020 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-32892855

RESUMO

Allergic contact hypersensitivity reactions of the oral mucosa pose a significant medical concern for some patients. Oral hypersensitivity reactions can result from a vast number of allergenic chemicals, but occur commonly from dental materials, flavorings, and preservatives. Clinical presentation is varied and often overlaps with other oral conditions, complicating their diagnosis and management. The most common clinical entities associated with oral hypersensitivity reactions are oral lichenoid reactions and allergic contact cheilitis. In addition to reviewing these conditions and their most common corresponding allergens, this article summarizes the pathogenesis of oral hypersensitivity reactions and addresses patch testing pearls.


Assuntos
Hipersensibilidade/diagnóstico , Hipersensibilidade/etiologia , Doenças da Boca/etiologia , Alérgenos/efeitos adversos , Queilite/etiologia , Humanos , Erupções Liquenoides/diagnóstico , Erupções Liquenoides/imunologia , Ativação Linfocitária , Doenças da Boca/diagnóstico , Doenças da Boca/imunologia , Testes do Emplastro
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...